Skip to main content

SuperMicrobiologists

How is microbiological sterility assessed for medical devices manufactured one at a time?

Published on 19 November 2025 6 min

When you produce one million vaccine doses, it’s “easy” to take a hundred of them for quality control. You test them, the tests are destructive, but there are still 999,999,900 doses left for patients.

But when you manufacture a medical device one by one… how can you perform microbiological testing without destroying it and without compromising its sterility?

To answer this question, we interviewed Atika AKAOUCH, who has over 15 years of experience in industrial microbiology and works at CARMAT, the French manufacturer of the artificial heart.

This field is highly confidential because many manufacturing steps are considered trade secrets… but in this article, we tried to uncover as much as possible about the microbiological testing performed!


Discover the Top 4 Rapid Micro Methods

We asked the SuperMicrobiologists in a big survey.
Here’s what they said.

Behind the Scenes of Microbiological Control at CARMAT’s Artificial Heart

Hello Atika, can you introduce your laboratory?

I work in the microbiology laboratory at CARMAT. We perform the quality control of the AesonⓇ artificial heart, as well as the monitoring of utilities (including process water) and the environmental monitoring of the cleanrooms.

What is your role at CARMAT?

I am the head of the microbiology and sterilization department. I am responsible for ensuring the microbiological cleanliness of the raw materials, the artificial heart, and its different components.

I also oversee the control of the manufacturing environment, including chemical, microbiological, and particulate contamination.

Ensuring the Sterility of an Artificial Heart: A One-of-a-Kind Challenge

Can you explain what CARMAT’s artificial heart is?

At CARMAT, we manufacture a Total Artificial Heart (TAH) called AesonⓇ. It is an artificial heart intended for patients with severe heart failure. It is a Class III medical device, implantable and active.

Is the device considered sterile at the time of implantation?

Yes, it is delivered sterile to hospitals.

What is the main microbiological challenge related to this product?

The main difficulty is that no other product is comparable to this one in terms of complexity, materials (plastic, metal, and biological components), and manufacturing process. We had to implement a unique testing strategy that allows us to perform microbiological analyses to ensure patient safety and to guarantee the sterility of the heart.

Sterility Assurance Strategy for the CARMAT Artificial Heart

In the pharmaceutical field, sterility testing is destructive. In your case, this doesn’t seem feasible. How do you verify the sterility of your medical device?

Indeed, we face a double challenge. We manufacture only one heart at a time, and the device is very costly. We therefore cannot perform destructive microbiological tests, as is done for other pharmaceutical products, because it would be too expensive… and above all, we simply wouldn’t have a heart left to supply if we had to destroy each one for testing.

Do you test each device individually, or only a representative sample from a batch?

We had to be creative to develop a strategy adapted to this type of product.

The first step is to control all the materials used, the process fluids (water and air), the production environments, and the personnel involved.

The second step is to periodically perform a full analysis on a finished device (intentionally sacrificed) to verify that the manufacturing process remains fully under control.

And how have the authorities reacted to this approach?

This plan has been submitted to and approved by the regulatory authorities (Europe and the US). During every audit, the strategy is reviewed and challenged to ensure that the process is fully controlled and understood.

So you’re running a lab where the “samples” cost far more than the reagents and consumables?

Oh yes, … much more. Every time I request an extra sample, management thinks twice before approving it!

What types of microbiological tests do you perform on the product?

We perform bioburden testing, endotoxin testing, and sterility testing.

Beyond the tests performed on the product and raw materials, do you also carry out environmental microbiological monitoring during manufacturing?

Yes, we actually perform a large amount of environmental monitoring. For certain production steps, the fine motor skills of human hands are the only way to assemble some components of the artificial heart. These are considered “high-risk” steps, involving human intervention in a Grade B environment. During these steps, we conduct extensive microbiological controls in our cleanrooms: air monitoring, surface monitoring, and personnel monitoring.

Which regulations do you follow? Medical device regulations or Pharmacopeia requirements?

That’s actually one of the challenges with this kind of medical device. For medical devices, we follow standards such as ISO 13485, but they do not always go far enough for our product. In those cases, we also rely on the American and European Pharmacopeias.

More recently, we have also implemented the European MDR 2017/745, which is the latest reference framework for medical devices.


Discover the Top 3 Bacterial Endotoxin Test Suppliers

We asked the SuperMicrobiologists in a big survey.
Here’s what they said.

The Future of Microbiological Control for Implantable Medical Devices

You mainly use “traditional” Pasteur-style methods. Would rapid methods be useful for this type of product?

Yes, definitely. In our specific case, using a rapid method wouldn’t necessarily allow us to release the product faster, because other steps in the process take longer. However, it would allow us to react much more quickly in the event of contamination.

For example, if an abnormal result appears during production, a rapid method would help us make a faster decision: either stop the manufacturing of the prosthesis (if it is contaminated, it is lost. We discard it and start a new one), or reprocess it when possible (disassembly, cleaning, sterilization). This prevents us from completing the entire production cycle with a product that is microbiologically non-compliant.

How do you see microbiological testing evolving for very high-value implantable devices?

I’m a big fan of new technologies, especially RMMs (Rapid Microbiological Methods). I’m convinced that using these methods, combined with continuous monitoring, will allow us to obtain faster and more reliable results, helping us anticipate contamination issues during production.

If you could improve or change one aspect of microbiological control for medical devices, what would you choose?

Use more rapid methods… of course!


A big thank you to Atika for taking the time to answer our questions!

Leave a Reply

Your email address will not be published. Required fields are marked *